Furthermore, we investigated whether RPN2 could regulate EGFR glycosylation in xenograft tumor tissues, and immunofluorescence staining showed that EGFR localization was altered and protein expression decreased by RPN2 silencing (Figure 5G). This evidence concerns the gene RPN2 and neoplasm.